[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1940

ACETYLGLYCARSENOBENZENE IN TREATMENT OF SYPHILIS: PRELIMINARY REPORT

Arch Derm Syphilol. 1940;42(6):1046-1058. doi:10.1001/archderm.1940.01490180055004
Abstract

Since Ehrlich's discovery of arsphenamine did not accomplish the desired millennium in the treatment of syphilis, scientific workers have been constantly seeking to improve the known methods of attack on this disease. These endeavors have been directed toward better management of the courses of treatment, modifications in the dosage of drugs, variations in the methods of administration and the addition of new chemical compounds. During the past two years we have conducted a clinical study with a new drug in 84 cases of various types of syphilis. An arsenical compound having the common name of acetylglycarsenobenzene was administered intramuscularly, together with an oil-soluble bismuth compound and insoluble mercury. The patients were a selected group who had not received previous antisyphilitic treatment. In each instance the diagnosis of syphilis was supported by a dark field examination or by a serologic test.

CHEMISTRY  Acetylglycarsenobenzene is chemically 3,4′-diacetylamino-4-hydroxyarsenobenzene 2′-sodium glycolate. The molecular weight

×